These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 12780666)

  • 21. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.
    Armenti VT; Radomski JS; Moritz MJ; Philips LZ; McGrory CH; Coscia LA
    Clin Transpl; 2000; ():123-34. PubMed ID: 11512306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. South American Heart Transplantation Registry of patients receiving everolimus in their immunosuppressive regimens.
    Bortman GV; Ceruti B; Ahualli L; Colque R; Amuchástegui M; Sgrosso JL; Muñoz J; Vulcano N; Burgos C; Diez F; Rodriguez MC; Perrone SV
    Transplant Proc; 2010; 42(1):324-7. PubMed ID: 20172342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
    Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcineurin inhibitors in heart transplantation.
    Keogh A
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S202-6. PubMed ID: 15093806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them.
    Shaw LM; Kaplan B; Kaufman D
    Clin Chem; 1996 Aug; 42(8 Pt 2):1316-21. PubMed ID: 8697605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation.
    Branco KC; Azeka E; Trindade E; Galas FR; Hajjar LA; Benvenuti L; Riso A; Tanamati C; Penha J; Auler JO; Jatene M
    Transplant Proc; 2012 Oct; 44(8):2483-5. PubMed ID: 23026625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes.
    Armenti VT; Moritz MJ; Davison JM
    Drug Saf; 1998 Sep; 19(3):219-32. PubMed ID: 9747668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular risk profile in kidney transplant recipients treated with two immunosuppressive regimens: tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine.
    Spagnoletti G; Citterio F; Favi E; Rossi E; Delreno F; De Santis I; Salerno MP; Gargiulo A; Castagneto M
    Transplant Proc; 2009 May; 41(4):1175-7. PubMed ID: 19460509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of quality of life in tacrolimus-based pediatric renal transplant recipients and their caregivers, including donors.
    Hasegawa A; Oshima S; Takahashi K; Uchida K; Ito K; Sonoda T
    Transplant Proc; 2005 May; 37(4):1771-3. PubMed ID: 15919461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
    Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug exposure and perceived adverse drug events reported by liver-transplant patients.
    Espinasse G; Kamar N; Hurault C; Suc B; Fourtanier G; Montastruc JL; Rostaing L; Bagheri H
    Int J Clin Pharmacol Ther; 2009 Mar; 47(3):159-64. PubMed ID: 19281724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excellent outcomes can be achieved in young pancreas transplant alone recipients by addition of sirolimus to maintenance immunosuppression regimen.
    Porubsky M; Gruessner AC; Rana A; Jie T; Gruessner RW
    Transplant Proc; 2014; 46(6):1932-5. PubMed ID: 25131074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group.
    Shield CF; McGrath MM; Goss TF
    Transplantation; 1997 Dec; 64(12):1738-43. PubMed ID: 9422413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcineurin inhibitors in renal transplantation: what is the best option?
    Tanabe K
    Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients.
    Manzarbeitia C; Reich DJ; Rothstein KD; Braitman LE; Levin S; Munoz SJ
    Liver Transpl; 2001 Feb; 7(2):93-9. PubMed ID: 11172391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.
    Plosker GL; Foster RH
    Drugs; 2000 Feb; 59(2):323-89. PubMed ID: 10730553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized, open-label preference study of two cyclosporine capsule formulations (usp modified) in stable solid-organ transplant recipients.
    Steinberg SM; Venuto RC; Kuruvila CK; Taylor DO; Anil Kumar MS; Groothuis JR; Ryan J; Greco R; Yeldandi V; Ashraf T; Boodhoo T;
    Clin Ther; 2003 Jul; 25(7):2037-52. PubMed ID: 12946549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.